Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 03, 2022

SELL
$2.7 - $4.3 $1.76 Million - $2.81 Million
-652,600 Reduced 39.49%
1,000,000 $2.75 Million
Q2 2022

Aug 12, 2022

BUY
$3.11 - $7.48 $2.44 Million - $5.86 Million
783,400 Added 90.13%
1,652,600 $5.16 Million
Q1 2022

May 16, 2022

BUY
$4.88 - $8.56 $2.9 Million - $5.08 Million
593,400 Added 215.16%
869,200 $6.75 Million
Q3 2021

Nov 09, 2021

BUY
$11.11 - $17.84 $1.46 Million - $2.34 Million
131,400 Added 91.0%
275,800 $3.11 Million
Q2 2021

Aug 13, 2021

SELL
$13.68 - $22.34 $4.86 Million - $7.94 Million
-355,600 Reduced 71.12%
144,400 $2.61 Million
Q1 2021

May 13, 2021

BUY
$9.0 - $63.91 $4.27 Million - $30.3 Million
474,100 Added 1830.5%
500,000 $11.4 Million
Q3 2020

Nov 12, 2020

SELL
$4.7 - $8.7 $85,070 - $157,470
-18,100 Reduced 41.14%
25,900 $126,000
Q2 2020

Aug 12, 2020

SELL
$5.54 - $10.81 $1.22 Million - $2.38 Million
-220,600 Reduced 83.37%
44,000 $313,000
Q1 2020

May 13, 2020

SELL
$2.47 - $21.36 $257,621 - $2.23 Million
-104,300 Reduced 28.27%
264,600 $1.82 Million
Q4 2019

Feb 10, 2020

BUY
$15.72 - $24.88 $366,276 - $579,704
23,300 Added 6.74%
368,900 $6.32 Million
Q3 2019

Nov 14, 2019

BUY
$24.74 - $49.3 $2.74 Million - $5.47 Million
110,900 Added 47.25%
345,600 $8.55 Million
Q2 2019

Aug 14, 2019

BUY
$34.66 - $63.73 $1.14 Million - $2.1 Million
32,900 Added 16.3%
234,700 $10.9 Million
Q1 2019

May 15, 2019

BUY
$64.85 - $100.15 $843,049 - $1.3 Million
13,000 Added 6.89%
201,800 $13.2 Million
Q4 2018

Feb 14, 2019

SELL
$65.89 - $165.64 $2.92 Million - $7.34 Million
-44,300 Reduced 19.0%
188,800 $13.3 Million
Q3 2018

Nov 14, 2018

BUY
$22.1 - $214.06 $5.15 Million - $49.9 Million
233,100 New
233,100 $33.5 Million

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $874M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.